 | Lyra Therapeutics, Inc. | |||
| NGM : LYRA || Location: United States | ||||
$5.210.0 (0.0%) |
0.23 M | 5.21 - 5.39 | ||
| Last Updated:America/New_York | Volume | Day range |
Total Call Open Interest - | Total Put Open Interest -
Today's Total Call volume - | Total Put volume -
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.223 M |
| March 15, 2024 | 0.206 M |
| Feb. 29, 2024 | 0.160 M |
| Feb. 15, 2024 | 0.185 M |
| Jan. 31, 2024 | 0.129 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.32 | -0.22 | 31.53% |
| 09/30/2023 | -0.32 | -0.27 | 16.77% |
| 06/30/2023 | -0.43 | -0.32 | 25.89% |
| 03/31/2023 | -0.37 | -0.44 | -18.18% |
| 12/31/2022 | -0.42 | -0.38 | 10.02% |
LYRA Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 59.743M | Shares Float | 26.228M |
| Short Float | 0.223M | Market Cap | 311.26M |
| Institution ownership | 84.67% | Insider ownership | 1.179% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.26 | Forward EPS | -1.11 |